We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · July 07, 2022

Hemodynamic Effects of Mirabegron in Patients With Advanced Heart Failure

Circulation: Heart Failure


Additional Info

Circulation: Heart Failure
Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial
Circ Heart Fail 2022 Jun 27;[EPub Ahead of Print], H Bundgaard, A Axelsson Raja, K Iversen, N Valeur, N Tønder, M Schou, AH Christensen, NE Bruun, H Søholm, M Ghanizada, NAS Fry, EJ Hamilton, S Boesgaard, MB Møller, E Wolsk, K Rossing, L Køber, HH Rasmussen, CR Vissing

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading